The lights have been turned on for the first time
At the intersection of physics and biology, researchers at Berkeley Lab and UC Berkeley have illuminated what was once invisible — the molecular architecture of life's smallest proteins. By reviving the century-old principle of phase contrast and threading it through the precision of cryo-electron microscopy, the team has effectively turned on the lights in a gallery that science has long navigated in the dark. The result is not merely a sharper image, but a wider window into the cellular world as it actually exists — dynamic, complex, and now, more legible than ever.
- For years, cryo-electron microscopy has struggled to resolve small, difficult proteins — a blind spot that has quietly constrained the frontiers of biological research.
- A laser-based phase plate, paired with a custom-built microscope called Theia, now delivers image clarity that surpasses existing cryo-EM systems, with hemoglobin — one of the hardest targets — showing the most dramatic improvement.
- More than 15 years of theoretical groundwork, precision machining, and partnership with Thermo Fisher Scientific were required to move this idea from concept to functioning instrument.
- The technology's true disruptive potential lies ahead: expanding from isolated protein imaging into cryo-electron tomography, which would allow scientists to observe molecular processes inside living cells in three dimensions.
A team of physicists at Berkeley Lab and UC Berkeley has cracked a longstanding problem in electron microscopy — the inability to clearly image very small molecules — by marrying an old optical principle with one of science's most powerful imaging tools.
The solution is a laser-based phase plate that works alongside a custom microscope called Theia, built in partnership with Thermo Fisher Scientific. The device bends laser light to sharpen the images produced by cryo-electron microscopy, which already magnifies objects roughly 10,000 times beyond what a standard light microscope can achieve. Physics professor Holger Müller, who led the effort, describes the before-and-after in vivid terms: examining proteins without the phase plate was like studying paintings in a pitch-dark gallery. The phase plate turns on the lights.
The gains were most pronounced with hemoglobin — a small protein near the lower limit of what current cryo-EM systems can resolve — and most meaningful when working with imperfect, difficult samples. That matters because real biological research rarely offers ideal conditions. The system's ability to extract usable data from challenging specimens expands the practical scope of what scientists can study.
Theia, even without the phase plate, already outperforms standard cryo-EM equipment. With it installed, Müller considers the instrument a contender for one of the world's best. The team is now preparing to extend its capabilities into cryo-electron tomography — a technique that assembles multiple angled images into full three-dimensional reconstructions, much like a medical CT scan. Unlike single-particle imaging, which photographs molecules in isolation, cryo-ET captures them inside living cells, in their native environment. For structural and cell biology, the ability to watch molecular processes unfold in actual biological context — at this level of resolution — represents a significant leap forward.
A team of physicists at Berkeley Lab and UC Berkeley has solved a problem that has haunted electron microscopy for years: the difficulty of seeing very small molecules clearly. They've done it by adapting an old imaging principle—phase contrast—to a cutting-edge technique called cryo-electron microscopy, or cryo-EM, which magnifies objects roughly 10,000 times more than a standard light microscope.
The breakthrough centers on a laser-based phase plate, a device that works in concert with a custom-built microscope called Theia, developed in partnership with Thermo Fisher Scientific. The phase plate bends laser light in a way that sharpens the images cryo-EM produces, making it possible to see molecular structures with unprecedented clarity. Holger Müller, a UC Berkeley physics professor who led the effort, describes the difference in stark terms: before the phase plate, studying protein structures with cryo-EM was like trying to examine paintings in a pitch-dark gallery. Now, he says, the lights are on.
The work did not happen overnight. More than 15 years of theoretical research and experimental refinement went into the project, supported by collaboration with skilled machinists and funding from Biohub. The payoff is tangible. When the team imaged two test proteins—aldolase, which is relatively straightforward to capture with existing cryo-EM systems, and hemoglobin, a smaller protein that sits near the lower limit of what current machines can resolve—the laser phase plate improved image resolution in both cases. The improvement was most dramatic for hemoglobin, the harder target.
Müller notes that the strongest gains came not from imaging well-prepared, large molecules but from tackling the most challenging specimens: small proteins with suboptimal preparation. This matters because real biological research often involves difficult samples. The system's ability to extract usable data from imperfect conditions expands what researchers can actually study.
Theia itself is no ordinary microscope. Even without the laser phase plate, it outperforms standard cryo-EM equipment. With the plate installed, Müller calls it a contender for one of the world's best instruments overall. The microscope is currently housed at UC Berkeley, where the research team is already planning its next phase of development.
That next phase involves expanding Theia's capabilities beyond single-particle analysis—the technique used to image isolated proteins—into cryo-electron tomography, or cryo-ET. Where single-particle cryo-EM photographs molecules in isolation, cryo-ET assembles multiple angled views of a molecule or cellular structure into a three-dimensional reconstruction, much like a medical CT scan builds a 3D image of the body from many 2D slices. The advantage is profound: cryo-ET captures molecules in their native environment, inside living cells, rather than in artificial isolation. This means researchers will be able to watch molecular processes unfold in their actual biological context, with resolution far superior to light microscopy. For cell biology and structural biology, the implications are substantial.
Citações Notáveis
Theia is the Formula 1 of microscopes. With the laser phase plate, we hope it becomes one of the world's best instruments overall.— Holger Müller, UC Berkeley physics professor
Before, studying structures with cryo-EM was like trying to look at paintings in a dark gallery. With Theia, it's like the lights have been turned on for the first time.— Holger Müller, UC Berkeley physics professor
A Conversa do Hearth Outra perspectiva sobre a história
Why does it matter that we can see hemoglobin more clearly? It's just a protein.
Hemoglobin is small—right at the edge of what cryo-EM can handle. If you can image it sharply, you've proven the system works on the hardest cases. And hemoglobin isn't just any protein; understanding its structure at atomic detail helps us design better drugs for blood disorders.
But we already knew hemoglobin's structure, didn't we?
We did, from older techniques. The point is that this new system can see it faster, clearer, and with less preparation fuss. That matters when you're trying to study variants or disease-related mutations.
What's the real difference between looking at a protein alone versus looking at it inside a cell?
Proteins don't exist alone in nature. They fold differently, interact with neighbors, get modified. Cryo-ET lets you see the actual molecular machinery at work in its real home. That's the leap.
How long until this technology is available to other labs?
Theia is at UC Berkeley now. Whether it gets replicated elsewhere depends on cost, demand, and whether Thermo Fisher decides to commercialize it. The phase plate itself is the real innovation—that's what other microscopes could theoretically adopt.
What happens if this works as well as they hope?
You'd see an acceleration in structural biology research. Drug design, disease understanding, cellular processes that were opaque become visible. It's not revolutionary in the sense of overturning what we know—it's revolutionary in speed and access.